The Prevent Coronary Artery Disease Trial

NCT06494501 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1600

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerotic Cardiovascular Disease

Interventions

DRUG: Inclisiran

Sponsor

Icahn School of Medicine at Mount Sinai